Biomarker Operations & Biospecimen Management Conference 2026

Almac Diagnostic Services are delighted to be attending and speaking at the Biomarker Operations & Biospecimen Management Conference 2026, taking place from the 16th – 17th November in Boston, USA.

About Biomarker Operations & Biospecimen Management Conference 2026

As trials expand globally and become more sample-intensive, protecting sample integrity and turning specimen data into trustworthy decisions has never mattered more. The inaugural Biomarker Operations & Biospecimen Management Summit provides a home to share experiences and define the standards this field now demands.

Following the complete sample lifecycle, from kit design and site collection, through to tracking, storage, biobanking, lab coordination and data harmonization, walk away with the real-time insights needed to implement robust, scalable biomarker and biospecimen operations.

Join 100+ fellow senior leaders from biopharma, labs, CROs, and biobanks, in the united mission of ensuring every sample is treated with the precision, rigor and care it requires.

To find out more, visit the Biomarker Operations & Biospecimen Management Conference website.

Our Team

Kevin Ellison

Head of Business Development US | Almac Diagnostic Services

kevin.ellison@almacgroup.com

Head of Business Development US | Almac Diagnostic Services

Our Team

Tom Fedolak

Senior Business Development Manager | Almac Diagnostic Services

thomas.fedolak@almacgroup.com

Senior Business Development Manager | Almac Diagnostic Services

Speaker

Gemma Logan

Associate Director | Project Management | Almac Diagnostic Services

gemma.logan@almacgroup.com

Associate Director | Project Management | Almac Diagnostic Services
0046f30f-f8f9-4025-88e6-55ed6c3a3eb7